Quick Takeaways
- Redmile Group, LLC filed SCHEDULE 13G/A for ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT).
- Disclosed ownership: 14%.
- Date of event: 30 Jun 2025.
Redmile Group, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT)
- Filing Manager
- Redmile Group, LLC
- Reporting Manager
- Redmile Group, LLC
- Symbol
- ADCT
- Shares outstanding
- 111,905,221 shares
- Disclosed Ownership
- 15,666,731 shares
- Ownership
- 14%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 16:15:34 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Redmile Group, LLC disclosed 14% ownership in ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Redmile Group, LLC | 14% | 15,666,731 | 0 | 15,666,731 | /s/ Jeremy C. Green | Managing Member | |
| Jeremy C. Green | 14% | 15,666,731 | 0 | 15,666,731 | /s/ Jeremy C. Green | Jeremy C. Green | |
| RedCo II Master Fund, L.P. | 12% | 13,145,712 | 0 | 13,145,712 | /s/ Jeremy C. Green | Managing Member of RedCo II (GP), LLC, general partner of RedCo II Master Fund, L.P. |